NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bell Therapeutics Inc.

Bell Therapeutics Inc.

Private
SeoulHealthcare & Life Scienceshttps://www.belltherapeutics.com/

Last Round

Grant

Oct 17, 2024

Total Funding Raised

$1.25M

Company Overview

Bell Therapeutics Inc. is a digital therapeutics company that develops neuroscience-based software solutions for treating conditions such as insomnia and hearing loss.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

digital therapeuticsDTxprescription digital therapeuticPDTsoftware as a medical deviceSaMDinsomnia treatmentauditory rehabilitationbiofeedbackneuroengineeringcochlear implant rehabilitationmental health techhealth techmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bell Therapeutics Inc. Comps

Public and private peers based on sector, stage, and business model.

Bell Therapeutics Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Bell Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 17, 2024
Early FundingJun 1, 2024
SeedSep 20, 2023

Key People

Founding team and executive leadership

Jay Lee

Chief Executive Officer

Executive Team

Bell Therapeutics Inc. Investors

Notable investors and investment history

Bell Therapeutics Inc. investors
InvestorRounds
SpringCampEarly Funding
FuturePlaySeed
Korea SMEs and Startups AgencySeed
HG InitiativeSeed
Government of South KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 20, 2023

    Secured funding from FuturePlay, HG Initiative, and Korea SMEs and Startups Agency.

Bell Therapeutics Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bell Therapeutics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bell Therapeutics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range13
Year Founded2023
Last FundingOct 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.